Can non-invasive tests substitute for histology in the diagnosis of Helicobacter pylori (Hp infection?

M. Hahn, D. O. Faigel, N. Magaret, David Lieberman, M (Brian) Fennerty

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: Rapid urease tests (RUT, e.g. CLOtest or Pyloritek) are performed during endoscopy to evaluate for Hp. RUT sensitivity varies from 80-90%, there-fore, many recommend histological examination of gastric biopsies to rule out Hp in RUT-negative patients. However, non-invasive tests may provide a more rapid diagnosis and be less expensive. Aim: Determine, if non-invasive tests (Urea Breath Test (UBT), serology, whole blood antibody tests) can substitute for histology in RUT-negative patients. Methods: 57 patients without prior treatment for Hp, not taking proton pump inhibitors, antibiotics, or bismuth within 4 weeks, underwent endoscopy for dyspepsia and tested RUT-negative (CLOtest or Pyloritek) by antral biopsy. All had the following: gastric biopsies (2 antral, 1 fundus; H&E, Alcian Yellow stain) examined for gastritis and Hp bacteria; 13C-UBT (Meretek; specimens mailed to the manufacturer for analysis); capillary blood by finger-prick for 3 commercially available tests: FlexSure HP (FS-WB, SmithKline Diagnostics, Inc. [SKD]), Quickview (QV, Quidel), and Accustat (Acc, Boehringer Mannheim) and one non-commercially available test (SDS, Saliva Diagnostic Systems); fresh serum for FlexSure HP (FS-Ser, SKD), and frozen serum sent to SKD for a commercially available EIA (HM-CAP). Hp was diagnosed if at least two of these three tests were positive: UBT, Hp identified on Histology, HM-CAP. Cost per patient ($US) was calculated using the cost per test plus the price of metronidazole, clarithromycin, and omeprazole treatment b.i.d. for 10 days ($200/patient) for all positive patients (AP) by each test. Results: AP TP AN TN Test Cost ($) Cost/Patient ($) Histology 2 2 55 53 199 206**UBT 10 4 47 47 125 164*HM-CAP 5 4 52 52 81 99*FS-WB 9 4 47 47 10 42 FS-Ser 7 4 48 48 10 35 QV 6 4 51 51 13 34 Acc 5 4 52 52 10 28 SDS 4 4 49 49 12 27 Excluded from analysis due to technical test failure: 1 FS-WB, 2 FS-Ser, 3 SDS. AP = All positive; TP = True positive; AN = All negative; TN = True negative.*p

Original languageEnglish (US)
JournalGastrointestinal Endoscopy
Volume47
Issue number4
StatePublished - 1998

Fingerprint

Helicobacter pylori
Histology
Breath Tests
Infection
Urea
Saliva
Costs and Cost Analysis
Biopsy
Endoscopy
Stomach
Bismuth
Clarithromycin
Omeprazole
Urease
Proton Pump Inhibitors
Dyspepsia
Metronidazole
Hematologic Tests
Gastritis
Serology

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Can non-invasive tests substitute for histology in the diagnosis of Helicobacter pylori (Hp infection? / Hahn, M.; Faigel, D. O.; Magaret, N.; Lieberman, David; Fennerty, M (Brian).

In: Gastrointestinal Endoscopy, Vol. 47, No. 4, 1998.

Research output: Contribution to journalArticle

@article{45b64e97558948bf88e93a9843a1924a,
title = "Can non-invasive tests substitute for histology in the diagnosis of Helicobacter pylori (Hp infection?",
abstract = "Introduction: Rapid urease tests (RUT, e.g. CLOtest or Pyloritek) are performed during endoscopy to evaluate for Hp. RUT sensitivity varies from 80-90{\%}, there-fore, many recommend histological examination of gastric biopsies to rule out Hp in RUT-negative patients. However, non-invasive tests may provide a more rapid diagnosis and be less expensive. Aim: Determine, if non-invasive tests (Urea Breath Test (UBT), serology, whole blood antibody tests) can substitute for histology in RUT-negative patients. Methods: 57 patients without prior treatment for Hp, not taking proton pump inhibitors, antibiotics, or bismuth within 4 weeks, underwent endoscopy for dyspepsia and tested RUT-negative (CLOtest or Pyloritek) by antral biopsy. All had the following: gastric biopsies (2 antral, 1 fundus; H&E, Alcian Yellow stain) examined for gastritis and Hp bacteria; 13C-UBT (Meretek; specimens mailed to the manufacturer for analysis); capillary blood by finger-prick for 3 commercially available tests: FlexSure HP (FS-WB, SmithKline Diagnostics, Inc. [SKD]), Quickview (QV, Quidel), and Accustat (Acc, Boehringer Mannheim) and one non-commercially available test (SDS, Saliva Diagnostic Systems); fresh serum for FlexSure HP (FS-Ser, SKD), and frozen serum sent to SKD for a commercially available EIA (HM-CAP). Hp was diagnosed if at least two of these three tests were positive: UBT, Hp identified on Histology, HM-CAP. Cost per patient ($US) was calculated using the cost per test plus the price of metronidazole, clarithromycin, and omeprazole treatment b.i.d. for 10 days ($200/patient) for all positive patients (AP) by each test. Results: AP TP AN TN Test Cost ($) Cost/Patient ($) Histology 2 2 55 53 199 206**UBT 10 4 47 47 125 164*HM-CAP 5 4 52 52 81 99*FS-WB 9 4 47 47 10 42 FS-Ser 7 4 48 48 10 35 QV 6 4 51 51 13 34 Acc 5 4 52 52 10 28 SDS 4 4 49 49 12 27 Excluded from analysis due to technical test failure: 1 FS-WB, 2 FS-Ser, 3 SDS. AP = All positive; TP = True positive; AN = All negative; TN = True negative.*p",
author = "M. Hahn and Faigel, {D. O.} and N. Magaret and David Lieberman and Fennerty, {M (Brian)}",
year = "1998",
language = "English (US)",
volume = "47",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Can non-invasive tests substitute for histology in the diagnosis of Helicobacter pylori (Hp infection?

AU - Hahn, M.

AU - Faigel, D. O.

AU - Magaret, N.

AU - Lieberman, David

AU - Fennerty, M (Brian)

PY - 1998

Y1 - 1998

N2 - Introduction: Rapid urease tests (RUT, e.g. CLOtest or Pyloritek) are performed during endoscopy to evaluate for Hp. RUT sensitivity varies from 80-90%, there-fore, many recommend histological examination of gastric biopsies to rule out Hp in RUT-negative patients. However, non-invasive tests may provide a more rapid diagnosis and be less expensive. Aim: Determine, if non-invasive tests (Urea Breath Test (UBT), serology, whole blood antibody tests) can substitute for histology in RUT-negative patients. Methods: 57 patients without prior treatment for Hp, not taking proton pump inhibitors, antibiotics, or bismuth within 4 weeks, underwent endoscopy for dyspepsia and tested RUT-negative (CLOtest or Pyloritek) by antral biopsy. All had the following: gastric biopsies (2 antral, 1 fundus; H&E, Alcian Yellow stain) examined for gastritis and Hp bacteria; 13C-UBT (Meretek; specimens mailed to the manufacturer for analysis); capillary blood by finger-prick for 3 commercially available tests: FlexSure HP (FS-WB, SmithKline Diagnostics, Inc. [SKD]), Quickview (QV, Quidel), and Accustat (Acc, Boehringer Mannheim) and one non-commercially available test (SDS, Saliva Diagnostic Systems); fresh serum for FlexSure HP (FS-Ser, SKD), and frozen serum sent to SKD for a commercially available EIA (HM-CAP). Hp was diagnosed if at least two of these three tests were positive: UBT, Hp identified on Histology, HM-CAP. Cost per patient ($US) was calculated using the cost per test plus the price of metronidazole, clarithromycin, and omeprazole treatment b.i.d. for 10 days ($200/patient) for all positive patients (AP) by each test. Results: AP TP AN TN Test Cost ($) Cost/Patient ($) Histology 2 2 55 53 199 206**UBT 10 4 47 47 125 164*HM-CAP 5 4 52 52 81 99*FS-WB 9 4 47 47 10 42 FS-Ser 7 4 48 48 10 35 QV 6 4 51 51 13 34 Acc 5 4 52 52 10 28 SDS 4 4 49 49 12 27 Excluded from analysis due to technical test failure: 1 FS-WB, 2 FS-Ser, 3 SDS. AP = All positive; TP = True positive; AN = All negative; TN = True negative.*p

AB - Introduction: Rapid urease tests (RUT, e.g. CLOtest or Pyloritek) are performed during endoscopy to evaluate for Hp. RUT sensitivity varies from 80-90%, there-fore, many recommend histological examination of gastric biopsies to rule out Hp in RUT-negative patients. However, non-invasive tests may provide a more rapid diagnosis and be less expensive. Aim: Determine, if non-invasive tests (Urea Breath Test (UBT), serology, whole blood antibody tests) can substitute for histology in RUT-negative patients. Methods: 57 patients without prior treatment for Hp, not taking proton pump inhibitors, antibiotics, or bismuth within 4 weeks, underwent endoscopy for dyspepsia and tested RUT-negative (CLOtest or Pyloritek) by antral biopsy. All had the following: gastric biopsies (2 antral, 1 fundus; H&E, Alcian Yellow stain) examined for gastritis and Hp bacteria; 13C-UBT (Meretek; specimens mailed to the manufacturer for analysis); capillary blood by finger-prick for 3 commercially available tests: FlexSure HP (FS-WB, SmithKline Diagnostics, Inc. [SKD]), Quickview (QV, Quidel), and Accustat (Acc, Boehringer Mannheim) and one non-commercially available test (SDS, Saliva Diagnostic Systems); fresh serum for FlexSure HP (FS-Ser, SKD), and frozen serum sent to SKD for a commercially available EIA (HM-CAP). Hp was diagnosed if at least two of these three tests were positive: UBT, Hp identified on Histology, HM-CAP. Cost per patient ($US) was calculated using the cost per test plus the price of metronidazole, clarithromycin, and omeprazole treatment b.i.d. for 10 days ($200/patient) for all positive patients (AP) by each test. Results: AP TP AN TN Test Cost ($) Cost/Patient ($) Histology 2 2 55 53 199 206**UBT 10 4 47 47 125 164*HM-CAP 5 4 52 52 81 99*FS-WB 9 4 47 47 10 42 FS-Ser 7 4 48 48 10 35 QV 6 4 51 51 13 34 Acc 5 4 52 52 10 28 SDS 4 4 49 49 12 27 Excluded from analysis due to technical test failure: 1 FS-WB, 2 FS-Ser, 3 SDS. AP = All positive; TP = True positive; AN = All negative; TN = True negative.*p

UR - http://www.scopus.com/inward/record.url?scp=33748983020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748983020&partnerID=8YFLogxK

M3 - Article

VL - 47

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 4

ER -